Vaxxinity
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$56,934 over the previous period. Total operating expenses were $56,051,000.
Profit Margin
| 2019 | 0 | -14.21M | |
|---|---|---|---|
| 2020 | 557K | -35.37M | -6351.35% |
| 2021 | 66K | -138.01M | -209113.64% |
| 2022 | 0 | -75.21M | |
| 2023 | 0 | -56.93K |
VAXX Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 66K | 557K | 0 |
Cost of revenue | 2.23M | 1.68M | 1.93M | 52K | 107K |
Gross profit | -2.23M | -1.68M | -1.87M | 505K | -107K |
Operating exp. | |||||
Research and development | 33.66M | 47.62M | 71.37M | 20.57M | 10.65M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 56.05M | 75.97M | 123.20M | 32.78M | 13.66M |
Operating income | -58.28M | -75.97M | -125.07M | -32.28M | -13.66M |
Other income (expenses), net | 58.22M | 757K | -12.1M | -7.67M | -502K |
Income before tax | -56.93K | -75.22M | -137.17M | -39.95M | -14.16M |
Income tax expense | -56.93K | -12K | 840K | -4.58M | 56K |
Net income | -56.93K | -75.21M | -138.01M | -35.37M | -14.21M |
Earnings per share | |||||
Basic EPS | -0.45 | -0.6 | -1.1 | -0.28 | -0.11 |
Diluted EPS | -0.45 | -0.6 | -1.1 | -0.28 | -0.11 |
| Data source | Data source | Data source |